Acadia Pharmaceuticals Inc. vs. Johnson & Johnson
Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ACAD | JNJ | |
|---|---|---|
| Market Cap | $3.67 billion | $675.03 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| ACAD | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.89% |
ACAD and JNJ split the dividend factors evenly.
Risk & Sentiment
| ACAD | JNJ | |
|---|---|---|
| Short Interest | 5.74% | 0.67% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: ACAD overview, ACAD financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.